mioflazine has been researched along with cardiovascular agents in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 5 (45.45) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conant, AR; Jarvis, SM | 1 |
Baer, HP; Moorji, A; Serignese, V; Van Belle, H | 1 |
Ijzerman, AP; Pirovano, IM; Van Belle, H | 1 |
Conant, AR; Griffith, DA; Jarvis, SM | 1 |
Beckeringh, JJ; Hendriks, MG; Hugtenburg, JG; Mathy, MJ; Van Marle, J; Van Veen, HA; Van Voorst, MJ; Van Zwieten, PA | 1 |
Buchwald, A; Ito, BR; Schaper, W | 1 |
Baer, HP; Ogbunude, PO | 1 |
Janssen, PA; Van Belle, H; Van den Broeck, WA; Wauquier, A | 1 |
Borgers, M; Liu, GS; Xhonneux, R | 1 |
Huang, DX; Liu, GS; Yang, XS | 1 |
Borgers, M; Flameng, W; Hermans, C; Vandeplassche, G; Xhonneux, R | 1 |
11 other study(ies) available for mioflazine and cardiovascular agents
Article | Year |
---|---|
Nucleoside transport in guinea-pig myocardium.
Topics: Adenosine; Animals; Biological Transport; Cardiovascular Agents; Cells, Cultured; Formycins; Guinea Pigs; Kinetics; Lidoflazine; Myocardium; Piperazines | 1991 |
In vivo effectiveness of several nucleoside transport inhibitors in mice and hamsters.
Topics: Adenosine; Administration, Oral; Animals; Biological Transport; Cardiovascular Agents; Cricetinae; Dilazep; Injections, Intraperitoneal; Mesocricetus; Mice; Mice, Inbred BALB C; Piperazines; Species Specificity; Thioinosine | 1991 |
Inhibition of nucleoside uptake in human erythrocytes by a new series of compounds related to lidoflazine and mioflazine.
Topics: Biological Transport, Active; Cardiovascular Agents; Erythrocytes; Humans; In Vitro Techniques; Kinetics; Lidoflazine; Ligands; Nucleosides; Piperazines; Uridine | 1990 |
Differential inhibition of nucleoside transport systems in mammalian cells by a new series of compounds related to lidoflazine and mioflazine.
Topics: Affinity Labels; Animals; Biological Transport; Cardiovascular Agents; Cattle; Cells, Cultured; Erythrocytes; Humans; Kidney; Lidoflazine; Nucleosides; Piperazines; Placenta; Rabbits; Rats; Sodium; Thioinosine; Uridine | 1990 |
The influence of nifedipine and mioflazine on mitochondrial calcium overload in normoxic and ischaemic guinea-pig hearts.
Topics: Animals; Antimony; Calcium; Cardiovascular Agents; Coronary Disease; Guinea Pigs; Homeostasis; In Vitro Techniques; Mitochondria, Heart; Myocardial Reperfusion; Nifedipine; Oxalates; Piperazines | 1990 |
Influence of mioflazine on canine coronary blood flow and on adenine nucleotide and nucleoside content under normal and ischemic conditions.
Topics: Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Animals; Blood Pressure; Cardiovascular Agents; Chromatography, High Pressure Liquid; Coronary Circulation; Coronary Disease; Dogs; Female; Heart Rate; Hemodynamics; Male; Piperazines | 1987 |
Binding of [G-3H]6-(4-nitrobenzylmercapto)purine ribonucleoside to isolated membranes. Inhibitory effect of mioflazine and its derivatives.
Topics: Animals; Binding Sites; Cardiovascular Agents; Cell Membrane; Cricetinae; Dilazep; In Vitro Techniques; Inosine; Liver; Lung; Male; Mesocricetus; Piperazines; Thioinosine | 1989 |
Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.
Topics: Administration, Oral; Animals; Caffeine; Cardiovascular Agents; Dogs; Drug Interactions; Electromyography; Electrooculography; Female; Male; Piperazines; Sleep | 1987 |
[Protective effects of lidoflazine and mioflazine in ischemic myocardium].
Topics: Animals; Calcium; Cardiovascular Agents; Coronary Disease; Female; Hemodynamics; In Vitro Techniques; Lidoflazine; Male; Myocardium; Piperazines; Rabbits | 1988 |
[Preventive effect of mioflazine on myocardial calcium-overload during postischemic reperfusion in the rabbit heart].
Topics: Animals; Cardiovascular Agents; Female; In Vitro Techniques; Male; Myocardial Reperfusion Injury; Piperazines; Rabbits | 1988 |
Beneficial effect of mioflazine in limiting myocardial infarct size in the anesthetized dog.
Topics: Anesthesia; Animals; Cardiovascular Agents; Dogs; Female; Male; Myocardial Infarction; Piperazines | 1984 |